Advertisement
Heart, Lung and Circulation

Prognostic Implication of Direct Cardiac Invasion from Lung Cancer in Non-Operatively Treated Patients Based on Lung Computed Tomography Imaging

Published:November 25, 2021DOI:https://doi.org/10.1016/j.hlc.2021.10.018

      Background

      Lung cancer with direct cardiac invasion (LCCI+) exerts a significant influence on the survival of patients. There is a paucity of comparative research into the prognosis of advanced lung cancer with and without direct cardiac invasion.

      Method

      In this study, 50 LCCI+ patients and 50 sex-, age-, and TNM stage-matched patients without direct cardiac invasion (LCCI) were retrospectively analysed. LCCI+ was defined as lung cancer directly invading the heart by penetrating mediastinum or extending into the atrium via the pulmonary vein. The study endpoint was all-cause death. In this study, the survival time was defined as the time from the first detection of direct cardiac invasion to the end of the event.

      Results

      During a median follow-up period of 31 months, all-cause death occurred in 44 patients (88.0%) in the LCCI+ group and in 36 patients (72.0%) in the LCCI group; the overall survival (OS) time among patients in the LCCI+ group was significantly lower compared with those in the LCCI group (5.0 [interquartile range (IQR), 2.0–12.0] vs 13.8 [IQR, 4.0–18.4] mo; p<0.001); the OS rate in the LCCI+ group was significantly lower compared with patients in the LCCI group (log-rank, p=0.0002). Multivariate Cox regression analysis showed that direct cardiac invasion was an independent predictor of survival in patients with advanced lung cancer (hazard ratio, 2.255; 95% confidence interval, 1.443–3.524). Further analysis indicated that in patients with small cell lung cancer, the survival rate between the LCCI+ group and LCCI group was insignificant (log-rank, p=0.075; survival time: 4.0 [IQR, 2.0–11.5] vs 11.5 [IQR, 5.0–18.3] mo); in patients with non-small cell lung cancer (NSCLC), the survival rate in the LCCI+ group was lower than that of the LCCI group (log-rank, p=0.01; survival time: 6.0 [IQR, 3.0–13.3] vs 16.3 [IQR, 10.4–27.2] mo).

      Conclusions

      Direct cardiac invasion from lung cancer was an independent prognostic factor for survival time in patients with lung cancer. Patients with direct cardiac invasion by NSCLC have a poorer clinical outcome than those without direct cardiac invasion. A careful preoperative evaluation is mandatory and appropriate management of cardiac involvement should be considered in the treatment of NSCLC.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ballo P.
        • Laureano R.
        • Briganti M.
        • Passaleva M.T.
        • Piani F.
        • Piga C.
        • et al.
        Left atrial mass invasion from pulmonary neoplasm extension via the right upper pulmonary vein presenting as ipsilateral stroke.
        Case Rep Med. 2016; 2016: 1-6
        • Pun S.C.
        • Plodkowski A.
        • Matasar M.J.
        • Lakhman Y.
        • Halpenny D.F.
        • Gupta D.
        • et al.
        Pattern and prognostic implications of cardiac metastases among patients with advanced systemic cancer assessed with cardiac magnetic resonance imaging.
        J Am Heart Assoc. 2016; 5: e003368
        • Milovanovic I.S.
        • Stjepanovic M.
        • Mitrovic D.
        Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: an autopsy study.
        Ann Thorac Med. 2017; 12: 191-198
        • Bisel H.F.
        • Wroblewski F.
        • LaDue J.S.
        Incidence and clinical manifestations of cardiac metastases.
        J Am Med Assoc. 1953; 153: 712-715
        • Budinger J.M.
        Untreated bronchogenic carcinoma: a clinicopathological study of 250 autopsied cases.
        Cancer. 1958; 11: 106-116
        • Strauss B.L.
        • Matthews M.J.
        • Cohen M.H.
        • Simon R.
        • Tejada F.
        Cardiac metastases in lung cancer.
        Chest. 1977; 71: 607-611
        • Kline I.K.
        Cardiac lymphatic involvement by metastatic tumor.
        Cancer. 1972; 29: 799-808
        • Tamura A.
        • Matsubara O.
        • Yoshimura N.
        • Kasuga T.
        • Akagawa S.
        • Aoki N.
        Cardiac metastasis of lung cancer: a study of metastatic pathways and clinical manifestations.
        Cancer. 2015; 70: 437-442
        • Kadappu K.K.
        • Rajaratnam R.
        • Kachwalla H.
        • Nguyen P.D.
        Lung cancer mimicking left atrial mass.
        Postgrad Med J. 2008; 84: 386-387
        • Sosvinska-Mielcarek K.
        • Senkus-Konefka E.
        • Jassem J.
        • Kulczycka J.
        • Jendrzejewski J.
        • Jaskiewicz K.
        Cardiac involvement at presentation of non-small-cell lung cancer.
        J Clin Oncol. 2008; 26: 1010-1011
        • Roy P.P.
        • Dwari A.K.
        • Dey S.K.
        • Sarkar A.
        • Bhattacharya A.
        • Saha A.K.
        A rare case of lung cancer with invasion in the heart giving rise to electrocardiographic features simulating myocardial infarction.
        J Indian Med Assoc. 2011; 109: 498-499
        • Detterbeck F.C.
        The eighth edition TNM stage classification for lung cancer: what does it mean on main street?.
        J Thorac Cardiovasc Surg. 2018; 155: 356-359
        • Butany J.
        • Leong S.W.
        • Carmichael K.
        • Komeda M.
        A 30-year analysis of cardiac neoplasms at autopsy.
        Can J Cardiol. 2005; 21: 675-680
        • Bussani R.
        • De-Giorgio F.
        • Abbate A.
        • Silvestri F.
        Cardiac metastases.
        J Clin Pathol. 2007; 60: 27-34
        • Dore R.
        • Alerci M.
        • D'Andrea F.
        • Di Giulio G.
        • De Agostini A.
        • Volpato G.
        Intracardiac extension of lung cancer via pulmonary veins: CT diagnosis.
        J Comp Assist Tomogr. 1988; 12: 565-568
        • Liaw C.-C.
        • Chang H.
        • Liao T.-Y.
        • Wen M.S.
        • Yu C.T.
        • Juan Y.H.
        The role of pulmonary veins in cancer progression from a computed tomography viewpoint.
        J Oncol. 2016; 2016: 1872627
        • Pitman A.G.
        • Solomon B.
        • Padmanabhan R.
        • McKenzie A.F.
        • Hicks R.J.
        Intravenous extension of lung carcinoma to the left atrium: demonstration by positron emission tomography with CT correlation.
        Br J Radiol. 2000; 73: 206-208
        • Guha P.
        • Sardar P.
        • Mookerjee S.
        • Guha S.
        Left atrial extension of lung carcinoma simulating myocardial infarction, unusual presentation: case report and literature review.
        Tanaffos. 2011; 10: 69-71
        • Takahashi K.
        • Furuse M.
        • Hanaoka H.
        • Yamada T.
        • Aburano T.
        Pulmonary vein and left atrial invasion by lung cancer: assessment by breath-hold gadolinium-enhanced three-dimensional MR angiography.
        J Comp Assist Tomogr. 2000; 24: 557-561
        • Riquet M.
        • Grand B.
        • Arame A.
        • Pricopi C.F.
        • Foucault C.
        • Dujon A.
        • et al.
        Lung cancer invading the pericardium: quantum of lymph nodes.
        Ann Thorac Surg. 2010; 90: 1773-1777
        • Harrer W.V.
        • Lewis P.L.
        Metastatic tumors involving the heart and pericardium.
        Pa Med. 1971; 74: 57-60
        • Nakamura A.
        • Suchi T.
        • Mizuno Y.
        The effect of malignant neoplasms on the heart: a study on the electrographic abnormalities and the anatomical findings in cases with and without cardiac involvement.
        Jpn Circ J. 1975; 39: 531-542
        • Scott R.W.
        • Garvin C.F.
        Tumors of the heart and pericardium.
        Am Heart J. 1939; 17: 431-436
        • Guha S.
        • Mookerjee S.
        • Karmakar R.N.
        • Mani S.
        • Pande A.
        • Bhattacharya R.
        • et al.
        Left atrial extension of lung malignancy with ECG changes resembling STEMI.
        Indian Heart J. 2010; 62: 81-83
        • Liaw C.C.
        • Chang H.
        • Yang T.S.
        • Wen M.S.
        Pulmonary venous obstruction in cancer patients.
        J Oncol. 2015; 2015: 210916
        • Gowda R.M.
        • Khan I.A.
        • Mehta N.J.
        • Gowda M.R.
        • Hyde P.
        • Vasavada B.C.
        • et al.
        Cardiac tamponade and superior vena cava syndrome in lung cancer – a case report.
        Angiology. 2004; 55: 691-695
        • Ackermann D.M.
        • Hyma B.A.
        • Edwards W.D.
        Malignant neoplastic emboli to the coronary arteries: report of two cases and review of the literature.
        Hum Pathol. 1987; 18: 955-959
        • Franciosa J.A.
        • Lawrison W.
        Coronary artery occlusion due to neoplasm: a rare cause of acute myocardial infarction.
        Arch Intern Med. 1971; 128: 797-801
        • Verma V.
        • Talmon G.A.
        • Zhen W.K.
        Intracardiac metastasis from non-small cell lung cancer.
        Front Oncol. 2015; 5: 168
        • Al-Mamgani A.
        • Baartman L.
        • Baaijens M.
        • De Pree L.
        • Incrocci L.
        • Levendag P.C.
        Cardiac metastases.
        Int J Clin Oncol. 2008; 13: 369-372
        • Tsuchiya R.
        • Asamura H.
        • Kondo H.
        • Goya T.
        • Naruke T.
        Extended resection of the left atrium, great vessels, or both for lung cancer.
        Ann Thorac Surg. 1994; 57: 960-965
        • Nakahara K.
        • Ohno K.
        • Mastumura A.
        • Hirose H.
        • Mastuda H.
        • Nakano S.
        • et al.
        Extended operation for lung cancer invading the aortic arch and superior vena cava.
        J Thorac Cardiovasc Surg. 1989; 97: 428-433
        • Dartevelle P.G.
        • Chapelier A.R.
        • Pastorino U.
        • Corbi P.
        • Lenot B.
        • Cerrina J.
        • et al.
        Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.
        J Thorac Cardiovasc Surg. 1991; 102: 259-265
        • Thomas P.
        • Magnan P.E.
        • Moulin G.
        • Giudicelli R.
        • Fuentes P.
        Extended operation for lung cancer invading the superior vena cava.
        Eur J Cardiothorac Surg. 1994; 8: 177-182
        • Raemdonck D.E.V.
        • Schneider A.
        • Ginsberg R.J.
        Surgical treatment for higher stage non-small cell lung cancer.
        Ann Thorac Surg. 1992; 54: 999-1013